Detalles de la búsqueda
1.
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.
Diabetes Obes Metab
; 26(6): 2229-2238, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38456579
2.
External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease.
Am Heart J
; 260: 72-81, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36841319
3.
Variability in benefit from intensive insulin therapy on cardiovascular events in individuals with type 1 diabetes: A post hoc analysis of the DCCT/EDIC study.
Diabet Med
; 40(11): e15183, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37470718
4.
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
Eur Heart J
; 43(18): 1715-1727, 2022 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35165703
5.
Balancing risks of recurrent venous thromboembolism and bleeding with extended anticoagulation: a decision analysis.
Res Pract Thromb Haemost
; 8(1): 102274, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38222076
6.
Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular disease.
Heart
; 110(7): 482-490, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38182277
7.
Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort.
Eur J Prev Cardiol
; 31(2): 182-189, 2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37793098
8.
Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM model.
Eur J Prev Cardiol
; 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38584392
9.
Visceral adipose tissue quantity and dysfunction and the occurrence of major bleeding in patients with established cardiovascular disease.
Obes Res Clin Pract
; 17(1): 40-46, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36464615
10.
The relevance of competing risk adjustment in cardiovascular risk prediction models for clinical practice.
Eur J Prev Cardiol
; 30(16): 1741-1747, 2023 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37338108
11.
Effect of adipose tissue quantity and dysfunction on the risk of cancer in individuals with and without type 2 diabetes.
Obes Res Clin Pract
; 17(5): 383-389, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37777400
12.
Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2).
Eur J Prev Cardiol
; 30(1): 61-69, 2023 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36208182
13.
Unexploited potential of risk factor treatment in patients with atherosclerotic cardiovascular disease.
Eur J Prev Cardiol
; 30(7): 601-610, 2023 05 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36757680
14.
Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2.
Eur J Prev Cardiol
; 30(15): 1705-1714, 2023 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37264679
15.
Cohort profile: the Utrecht Cardiovascular Cohort-Second Manifestations of Arterial Disease (UCC-SMART) Study-an ongoing prospective cohort study of patients at high cardiovascular risk in the Netherlands.
BMJ Open
; 13(2): e066952, 2023 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36806141
16.
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP.
Eur J Prev Cardiol
; 30(1): 8-16, 2023 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35972749
17.
Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment.
Open Heart
; 9(1)2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35459718
18.
Residual cardiovascular risk reduction guided by lifetime benefit estimation in patients with symptomatic atherosclerotic disease: effectiveness and cost-effectiveness.
Eur J Prev Cardiol
; 29(4): 635-644, 2022 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34009323
19.
Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention.
Clin Epidemiol
; 13: 813-823, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34566434
20.
Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular disease.
Heart
; 106(21): 1686-1692, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32170038